Balanced news tone
News Sentiment
STTK sentiment intelligence
Shattuck Labs Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-5.8% over one week, +34.4% over four weeks, trend active, and materially above fair value.
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update - Slideshow (NASDAQ:STTK) 2026-07-08
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update - Slideshow (NASDAQ:STTK) 2026-07-08
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 23:32
- Source
- Seeking Alpha
Shattuck Labs (STTK) CTO exercises options and makes small 10b5-1 sale
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 23:00
- Source
- Stock Titan
Shattuck Labs focuses on immunotherapy pipeline as investors watch clinical milestones
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 14:50
- Source
- Ad-hoc-news.de
Shattuck Labs (STTK) CMO sells 30,000 shares under 10b5-1 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 00:21
- Source
- Stock Titan
Shattuck Labs (NASDAQ: STTK) CTO option exercises and 23,465-share sale disclosed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
410-share sale reported by STTK insider (NASDAQ: STTK) via option exercise
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
STTK (NASDAQ) files Rule 144 notice for stock-option sale on 06/30/2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
Price to sales forward of Shattuck Labs, Inc. – NASDAQ:STTK
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 17:53
- Source
- TradingView
Shattuck Labs (NASDAQ: STTK) launches stock and pre-funded warrant offering at $4.00
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Stock Titan
Shattuck Labs Prices $75 Million Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 10:13
- Source
- MT Newswires
Shattuck Labs prices $75M public offering at $4 per share
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Investing.com
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 04:21
- Source
- GlobeNewswire
Shattuck Labs Launches Public Offering of Common Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 20:36
- Source
- MT Newswires
Shattuck Labs, Inc. Announces Proposed Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 20:18
- Source
- GlobeNewswire
Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 12:00
- Source
- GlobeNewswire
Why is Shattuck Labs stock up 14% today? By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Investing.com South Africa
Shattuck Labs, Inc. Announces Public Offering of Common Stock and Pre-Funded Warrants
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Quiver Quantitative
Shattuck Labs Reports Good Safety Results for Phase 1 Study of Drug Candidate for Immune-Related Disease
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jun 2026 11:03
- Source
- MT Newswires
Shattuck Labs Announces Phase 1 Results for SL-325
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jun 2026 10:00
- Source
- GlobeNewswire
Shattuck Labs (STTK) Reports Positive Phase 1 Trial Outcomes for SL-325
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- GuruFocus
Shattuck Labs stock jumps 17% on Phase 1 trial results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jun 2026 07:00
- Source
- Investing.com
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 20:05
- Source
- GlobeNewswire
Citigroup Upgrades Shattuck Labs to Buy From Neutral, Price Target is $7
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 05 Jun 2026 11:20
- Source
- MT Newswires
Shattuck Labs to Present Phase 1 Clinical Data for SL-325 and Pipeline Update on June 8, 2026 | STTK Stock News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Quiver Quantitative
Here's Why We're Not Too Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 18 May 2026 07:00
- Source
- simplywall.st
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 11 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st